Latest Breaking News On - Prnewswire redhill biopharma ltd - Page 16 : comparemela.com

RedHill Biopharma Announces $10 Million Bought Deal Offering of American Depositary Shares USA - English Share this article TEL AVIV, Israel and RALEIGH, N.C., March 1, 2021  /PRNewswire/ RedHill Biopharma Ltd . (Nasdaq: RDHL) ( RedHill or the Company ), a specialty biopharmaceutical company, today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co., LLC under which the underwriter has agreed to purchase on a firm commitment basis 1,250,000 American Depositary Shares (ADSs) of the Company, at a price to the public of $8.00 per ADS, less underwriting discounts and commissions. Each ADS represents ten ordinary shares, par value NIS 0.01 per share, of the Company. The closing of the offering is expected to occur on or about March 4, 2021, subject to satisfaction of customary closing conditions.

New yorkUnited statesBryan gibbsRedhill biopharmaAdi frishRedhill biopharma ltdExchange commissionCompany annual report on formAmerican depositary shares adss of the companyCompany expanded access programHc wainwright coCorporate business developmentPrnewswire redhill biopharma ltdDepositary sharesHill biopharmaPrivate securities litigation reform act